濮阳东方医院男科看早泄好不-【濮阳东方医院】,濮阳东方医院,濮阳东方医院看男科口碑好很放心,濮阳东方妇科导航,濮阳东方妇科医院技术非常专业,濮阳东方医院看男科评价非常高,濮阳东方妇科附近站牌,濮阳东方医院治疗早泄技术值得信任
濮阳东方医院男科看早泄好不濮阳东方医院男科割包皮手术费用价格,濮阳东方医院口碑好很放心,濮阳东方医院男科治阳痿技术比较专业,濮阳东方医院治疗早泄很靠谱,濮阳东方妇科坐公交路线,濮阳东方妇科线上挂号,濮阳东方医院男科割包皮手术口碑怎么样
The U.S. will pay more than billion for 100 million doses of a potential Covid-19 vaccine manufactured by Johnson & Johnson.The deal is one of several large agreements between the government and pharmaceutical companies as part of Operation Warp Speed, aimed at creating, testing, manufacturing and distributing a Covid-19 vaccine quickly.The Trump administration’s deal with Johnson & Johnson, announced Wednesday, allows for the purchase of an additional 200 million doses.Johnson & Johnson’s vaccine, developed by subsidiary Janssen Pharmaceutical Companies, has shown positive preclinical results. Testing of their vaccine is currently underway with human trials in the United States and Belgium.The Johnson & Johnson vaccine testing is reportedly behind some of the more advanced-stage potential vaccines, like those from Moderna, Pfizer and AstraZeneca, which have begun phase three human trials.“We greatly appreciate the U.S. government’s confidence in, and support for, our R&D platform and efforts and the scalability of our vaccine technology. We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson in a statement.The company says they are committed to global access to the vaccine following approvals, and has a goal of supplying 1 billion doses globally through the end of 2021. 1493
The US Food and Drug Administration pressed forward with its investigation of e-cigarette companies Friday, sending letters to 21 companies in an effort to uncover whether they are marketing products illegally and outside the agency's compliance policy.This latest phase of the investigation addresses more than 40 e-cigarette products and is part of the agency's ongoing efforts to combat e-cigarette use among youth. It also comes less than two weeks after the agency conducted a surprise inspection of e-cigarette maker Juul's corporate headquarters in San Francisco, seizing thousand of documents, many of which relate to its sales and marketing practices."Companies are on notice," FDA Commissioner Dr. Scott Gottlieb said in a statement Friday. "The FDA will not allow the proliferation of e-cigarettes or other tobacco products potentially being marketed illegally and outside of the agency's compliance policy, and we will take swift action when companies are skirting the law."In September, Gottlieb called the increasing teen use of e-cigarettes "an epidemic," adding that teen nicotine use is dangerous to young people's health and brains.Federal law prohibits the sale of e-cigarettes to people under the age of 18, but more than 2 million middle and high school students were current users of e-cigarettes in 2017, according to the FDA. The US Centers for Disease Control and Prevention says it's the most common nicotine product used by middle and high schoolers.Also last month, the FDA requested that five major e-cigarette manufacturers, including Juul, explain how they plan to combat the use of their products by minors. The agency said it was looking into steps to eliminate the sale of flavored products and unveiled a public education campaignabout e-cigarettes.The FDA said it's considering civil and criminal avenues to enforce these regulations, including fines, seizures and injunctions, according to Friday's announcement.CNN reached out to some of the companies that received letters for comment but did not immediately receive a response."We're going to address issues related to the access kids have to e-cigarettes, as well as the youth appeal of these products," Gottlieb said Friday. "We know flavors are one of the principal drivers of the youth appeal of e-cigarettes and we're looking carefully at this."No reasonable person wants to see these products reaching epidemic use among kids," he said. 2500
The Smithsonian National Zoo in Washington is welcoming its newest member — a baby Lowland gorilla.On Sunday, 15-year-old Calaya gave birth to a son, Moke — "junior" or "little one" in Lingala, a language spoken in Central Africa.“The birth of this western lowland gorilla is very special and significant, not only to our Zoo family but also to this critically endangered species as a whole,” said Meredith Bastian, the National Zoo's curator of primates, according to the Smithsonian. “The primate team’s goal was to set Calaya up for success as best we could, given that she is a first-time mother. Doing so required great patience and dedication on the part of my team, and I am very proud of them and Calaya.”According to the zoo, Cayala has been adjusting well to motherhood and has learned how to care for Moke by watching other gorillas and through the help of staff. Zookeepers helped trained Cayala, in part, by showing her pictures of mother gorillas and presenting her with toys to cuddle and kiss.“This infant’s arrival triggers many emotions—joy, excitement, relief—and pride that all of our perseverance in preparing Calaya for motherhood has paid off,” said animal keeper Melba Brown. “We will provide support to her if need be, but I have every confidence that Calaya will be a great mom to Moke. I am excited to see how he will fit into the group dynamic. There are a lot of different personalities in this family troop, but they all work well together.”Alex Hider is a writer for the E.W. Scripps National Desk. Follow him on Twitter @alexhider. 1581
Mark Ostrowski with Check Point Software.The security company says coronavirus-related cyber attacks are down since the summer, but the number of malicious websites related to COVID-19 vaccines is up.The warnings were reiterated Wednesday by French-based international policing agency Interpol, which issued a global alert that organized crime groups may be attempting to sell stolen vaccines or set up scams with the promise of vaccines. So-called "threat actors" are sending out vaccine-related email phishing campaigns. A recent one had the email subject: "Urgent information letter: COVID-19 new approved vaccines."“So, what I would really warn folks is that if you receive an email that contains a vaccine sort of sensational type of subject in the email itself, and then there's an attachment, and the attachment is either an executable or office document, those are things that you want to watch out for,” said Ostrowski.People who opened that document in the phishing email actually had a way to steal usernames and passwords.You should only get your vaccine-related information from trusted news or government websites, not your inbox.“This is just the next thing, right. So, every time there's a new announcement, that specific subject, that specific entity, that's tied to say a vaccine is what's going to become the next target, right. So, these threat actors are very, very closely monitoring the global pandemic and then using those moments to quickly make and adjust their attack methods.” 1806
The US officially relocated its Embassy to Jerusalem on Monday, formally upending decades of American foreign policy in a move that was met with clashes and protests along the Israeli-Gaza border.At least 43 Palestinians were killed in Gaza as deadly protests took place ahead of and during the ceremony in Jerusalem — making it the deadliest day there since the 2014 Gaza war.President Donald Trump did not attend the ceremony in Jerusalem's Arnona neighborhood, but in a video message broadcast at the event he congratulated Israel, saying the opening had been "a long time coming.""Today, Jerusalem is the seam of Israel's government. It is the home of the Israeli legislature and the Israeli supreme court and Israel's prime minister and president. Israel is a sovereign nation with the right like every other sovereign nation to determine its own capital, yet for many years, we failed to acknowledge the obvious, the plain reality that Israel's capital is Jerusalem," Trump said in the pre-recorded remarks. 1021